We validated well-known somatic mutations in CRC, such as TP53, APC, KRAS and discovered a few high prevalent novel somatic mutations, including PEG3 and PTPRT. Their mutation frequencies were also compared with that in TCGA data, and significant alternative frequency in APC or PEG3 was observed. This evidence concerns the gene TP53 and colorectal carcinoma.